David A Morrow Selected Research

Acute Coronary Syndrome

1/2022	Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.
1/2021	Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36.
12/2020	Practice pattern of use of high sensitivity troponin in the outpatient settings.
1/2020	Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.
1/2019	Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.
1/2019	Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).
1/2019	Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes.
10/2018	Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.
1/2018	High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
1/2018	Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Morrow Research Topics

Disease

139	Myocardial Infarction 01/2022 - 06/2002
133	Acute Coronary Syndrome 01/2022 - 02/2002
66	Heart Failure 01/2022 - 05/2004
56	ST Elevation Myocardial Infarction 01/2022 - 07/2002
43	Ischemia 01/2022 - 04/2003
41	Hemorrhage 01/2022 - 04/2005
39	Stroke (Strokes) 01/2022 - 08/2006
25	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 11/2002
24	Atherosclerosis 01/2022 - 02/2003
23	Thrombosis (Thrombus) 01/2022 - 07/2002
23	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 04/2002
18	Peripheral Arterial Disease 10/2021 - 09/2009
17	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
17	Unstable Angina 02/2017 - 06/2002
16	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 07/2002
14	Inflammation (Inflammations) 01/2022 - 02/2003
14	Hypertension (High Blood Pressure) 01/2021 - 02/2003
13	Diabetes Mellitus 11/2021 - 04/2006
12	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2014
11	Cardiogenic Shock 12/2021 - 09/2010
11	Ischemic Stroke 04/2021 - 09/2009
10	Atrial Fibrillation 01/2022 - 01/2015
10	Infarction (Infarctions) 11/2021 - 07/2002
10	Infections 01/2020 - 10/2005
9	COVID-19 01/2022 - 01/2020
8	Shock 01/2022 - 01/2019
8	Necrosis 01/2016 - 01/2003
7	Coronary Disease (Coronary Heart Disease) 09/2016 - 02/2003
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2014 - 10/2005
6	Chronic Renal Insufficiency 01/2021 - 04/2006
6	Transient Ischemic Attack 01/2019 - 12/2014
5	Respiratory Insufficiency (Respiratory Failure) 04/2022 - 01/2018
5	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2019
5	Ventricular Tachycardia 01/2021 - 08/2010
5	Chest Pain (Chest Pains) 12/2020 - 09/2013
4	Fibrosis (Cirrhosis) 01/2021 - 01/2012
4	Heart Diseases (Heart Disease) 01/2019 - 12/2010
4	Vascular Diseases (Vascular Disease) 11/2018 - 08/2003

Drug/Important Bio-Agent (IBA)

72	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2002
37	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 02/2002
31	C-Reactive ProteinIBA 01/2022 - 04/2002
30	TroponinIBA 01/2022 - 07/2002
25	vorapaxarIBA 10/2021 - 09/2009
24	Ranolazine FDA Link 01/2021 - 06/2006
23	Neurofibromin 2 (Merlin)IBA 01/2021 - 06/2006
22	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 06/2002
21	Troponin IIBA 01/2021 - 04/2002
18	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 11/2005
16	Natriuretic PeptidesIBA 01/2021 - 01/2003
16	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 02/2005
15	Troponin T (Troponin T1)IBA 01/2022 - 07/2002
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 10/2005
13	Clopidogrel (Plavix)FDA Link 01/2020 - 12/2005
12	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
11	AnticoagulantsIBA 01/2022 - 03/2005
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2005
11	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 05/2005
11	Atorvastatin (Lipitor)FDA Link 06/2011 - 05/2005
10	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
10	Enalapril FDA LinkGeneric 01/2021 - 01/2018
10	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2018
10	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2002
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 06/2007
7	CreatinineIBA 01/2022 - 11/2003
7	Thrombin FDA Link 10/2019 - 04/2005
7	AntithrombinsIBA 09/2010 - 08/2004
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
6	Growth Differentiation Factor 15IBA 01/2021 - 10/2010
5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 06/2015
5	oxidized low density lipoproteinIBA 01/2022 - 05/2005
5	saxagliptin FDA Link 11/2021 - 10/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2006
5	TicagrelorIBA 11/2020 - 09/2016
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
5	alogliptinIBA 01/2018 - 01/2017
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 04/2006
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014 - 11/2005
5	N(2)-(3-trifluoromethylphenyl)guanineIBA 11/2011 - 07/2002
5	CalciumIBA 10/2007 - 11/2005
4	Thromboplastin (Tissue Factor)IBA 01/2022 - 04/2005
4	LipidsIBA 10/2021 - 08/2006
4	SodiumIBA 01/2021 - 06/2006
4	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2009
4	Cystatin CIBA 01/2019 - 01/2018
4	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 03/2007
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 09/2009
4	Peroxidase (Myeloperoxidase)IBA 01/2016 - 05/2007
4	Pharmaceutical PreparationsIBA 06/2015 - 06/2007
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2014 - 03/2007

Therapy/Procedure

81	Therapeutics 04/2022 - 07/2002
24	Percutaneous Coronary Intervention 11/2021 - 11/2003
19	Secondary Prevention 10/2021 - 09/2009
14	Critical Care (Surgical Intensive Care) 01/2022 - 01/2015
11	Thrombolytic Therapy 09/2010 - 11/2004
6	Patient Readmission 01/2021 - 02/2004
6	Stents 01/2020 - 05/2006
4	Noninvasive Ventilation 04/2022 - 01/2020
4	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2019
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2020
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 09/2008